Comparison of Two Different Intraocular Lenses Implanted With Yamane Technique

October 3, 2023 updated by: Johannes Kepler University of Linz

Evaluation of Two Different Intraocular Lens Models After Lens Implantation Using the Yamane Technique

In case of instability or rupture of capsular bag occurs during cataract surgery, Yamane technique is one of the options to fix intracocularlens' haptics. Yamane technique uses a double-needle technique that seamlessly fixes the haptics intrascleral by creating a scleral tunnel.

Aberrations, IOL tilting or even dislocations might occur and influence the final outcome of IOL implantation.

The aim of this study is the evaluation of the postoperative tilt of Kowa PU6AS using Yamane technique. Furthermore of the corrected and uncorrected visual acuity and the anterior chamber depth are being developed.

Study Overview

Detailed Description

During uncomplicated cataract surgery, an intraocular lens (IOL) is implanted into the patient's capsular bag. If increased instability or rupture of this capsular bag occurs due to aggravated intraoperative conditions or IOL dislocation, several options are available to the surgeon to correct the aphakia, all characterized by their respective advantages and disadvantages, but with no clear superiority of any one method.

The popular Yamane technique, or "flanged IOL fixation", uses a double-needle technique that seamlessly fixes the haptics intrascleral by creating a scleral tunnel using two 30-gauge needles.

Examples of lenses used for this purpose are the TECNIS ZA9003 (Johnson&Johnson, USA) and the Kowa PU6AS (Kowa, Japan). Another approach is the Carlevale FIL-SSF IOL (Soleko, Italy), which was developed specifically for use in aphakia with lack of capsular stability.

All types of implantation are not immune to aberrations, tilting or even dislocation. Many factors influence the final outcome of IOL implantation, be it the optimal choice of intraocular lens power, the surgeon's experience regarding fixation in more challenging eyes, or individual anatomical conditions. As part of quality assurance, an evaluation of monthly and six-monthly data will now be performed. The aim of this study is the evaluation of the postoperative tilt of the Kowa PU6AS in Yamane technique, as well as the evaluation of the corrected and uncorrected visual acuity and the anterior chamber depth within the clinical quality management.

Study Type

Observational

Enrollment (Estimated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Upper Austria
      • Linz, Upper Austria, Austria, 4020
        • Recruiting
        • Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz
        • Sub-Investigator:
          • Nino Hirnschall, MD
        • Contact:
        • Contact:
        • Principal Investigator:
          • Matthias Bolz, MD
        • Sub-Investigator:
          • Marina Casazza, MD
        • Sub-Investigator:
          • Jan Rothbächer, MD
        • Sub-Investigator:
          • Sophia Reifeltshammer, BSc
        • Sub-Investigator:
          • Leon Pomberger, MD
        • Sub-Investigator:
          • Klemens Waser, MD
        • Sub-Investigator:
          • Siegfried Mariacher, MD
        • Sub-Investigator:
          • Haidar Khalil, MD
      • Linz, Upper Austria, Austria, 4020
        • Recruiting
        • Department for Ophthalmology and Optometry
        • Sub-Investigator:
          • Sophia Reifeltshammer, BSc
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Only patients who are undergoing (underwent)routine secondary cataract surgery will be included in this study.

Description

Inclusion Criteria:

  • Minimum age: 21 Years
  • planned or performed lens implantation using the Kowa PU6AS or the Johnson & Johnson ZA9003 using the Yamane technique
  • signed patient consent form

Exclusion Criteria:

  • best corrected visual acuity >0.1 (Snellen)
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Kowa Group
Patients who had a Kowa lens implanted using the Yamane technique
Biometry using the IOL Master 700
Anterior segment-OCT to evaluate lens tilt
Corneal Topography using the MS-39
Abberometry using the OSIRIS-Abberometer
Evaluation of Refraction using an Autorefractor
Refraction performed by experienced staff
Slit Lamp Examination
Johnson
Patients who had the ZA9003 (J&J) lens implanted using the Yamane technique
Biometry using the IOL Master 700
Anterior segment-OCT to evaluate lens tilt
Corneal Topography using the MS-39
Abberometry using the OSIRIS-Abberometer
Evaluation of Refraction using an Autorefractor
Refraction performed by experienced staff
Slit Lamp Examination

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Tilt
Time Frame: 6 Weeks
Postoperative Tilt
6 Weeks
Autorefraction
Time Frame: 6 Weeks
Refraction using an automated refractor
6 Weeks
Subjective Refraction
Time Frame: 6 Weeks
Refraction performed by experienced staff
6 Weeks
Best corrected visual acuity
Time Frame: 6 Weeks
Measurement performed by experienced staff
6 Weeks
uncorrected visual acuity
Time Frame: 6 Weeks
Measurement performed by experienced staff
6 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Matthias Bolz, MD, JKU Linz

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Estimated)

May 1, 2024

Study Completion (Estimated)

May 1, 2025

Study Registration Dates

First Submitted

June 12, 2023

First Submitted That Met QC Criteria

June 12, 2023

First Posted (Actual)

June 22, 2023

Study Record Updates

Last Update Posted (Actual)

October 5, 2023

Last Update Submitted That Met QC Criteria

October 3, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • KUK-Ophthalmology-012

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aphakia

Clinical Trials on IOL Master 700

Subscribe